about
(11)C[double bond, length as m-dash]O bonds made easily for positron emission tomography radiopharmaceuticalsPET neuroimaging studies of [(18)F]CABS13 in a double transgenic mouse model of Alzheimer's disease and nonhuman primatesSynthesis of [(11)C]Bexarotene by Cu-Mediated [(11)C]Carbon Dioxide Fixation and Preliminary PET Imaging.PET imaging of fatty acid amide hydrolase with [(18)F]DOPP in nonhuman primates.Practical Radiosynthesis and Preclinical Neuroimaging of [11C]isradipine, a Calcium Channel Antagonist.Synthesis and Preliminary PET Imaging Studies of a FAAH Radiotracer ([¹¹C]MPPO) Based on α-Ketoheterocyclic Scaffold.Synthesis and Preclinical Evaluation of Sulfonamido-based [(11)C-Carbonyl]-Carbamates and Ureas for Imaging Monoacylglycerol Lipase.11CO2 fixation: a renaissance in PET radiochemistry.Alternative approaches for PET radiotracer development in Alzheimer's disease: imaging beyond plaque.Small heterocycles in multicomponent reactions.Mechanistic Studies and Radiofluorination of Structurally Diverse Pharmaceuticals with Spirocyclic Iodonium(III) Ylides.Metal-free 18F-labeling of aryl-CF2H via nucleophilic radiofluorination and oxidative C-H activation.Development of [18F]Maleimide-Based Glycogen Synthase Kinase-3β Ligands for Positron Emission Tomography Imaging.Stereocontrolled disruption of the Ugi reaction toward the production of chiral piperazinones: substrate scope and process development.Spirocyclic hypervalent iodine(III)-mediated radiofluorination of non-activated and hindered aromatics.Conformational modulation of in vitro activity of cyclic RGD peptides via aziridine aldehyde-driven macrocyclization chemistry.Solvatochromic Reagents for Multicomponent Reactions and their Utility in the Development of Cell-Permeable Macrocyclic Peptide VectorsThioester-isocyanides: versatile reagents for the synthesis of cycle-tail peptidesShifting the energy landscape of multicomponent reactions using aziridine aldehyde dimers: a mechanistic studyRapid microfluidic flow hydrogenation for reduction or deprotection of 18F-labeled compoundsRhodium-Catalyzed Addition of Organozinc Iodides to Carbon-11 IsocyanatesCurrent and Future Cardiovascular PET RadiopharmaceuticalsFacile 18F labeling of non-activated arenes via a spirocyclic iodonium(III) ylide method and its application in the synthesis of the mGluR5 PET radiopharmaceutical [18F]FPEB
P50
Q28066107-41098DD5-FCF0-45E4-A0E2-4AEEBBD9F1F3Q28833503-D52678C3-B33B-4D70-85DA-2A7BDA910057Q33461960-C76EB5A8-68EC-46EA-8DB8-9F6ED7858E57Q34473739-557CBA94-1B1E-41B4-8967-B12C2122FF40Q36909610-E3747DEF-C93F-4C2C-9A4D-3B3FEC3736DAQ36926261-5115333A-65C0-4B95-9AD7-49B992A39175Q36970368-FCA6DB6D-91E0-4BC7-B9E3-440D94E23368Q38106855-CB71C439-6CE8-42B6-A41A-A90A1AD9DF75Q38170338-0A2044F9-737C-45F7-A5E5-DF5852FCEB7FQ38230561-6BE13BED-AB3E-48DC-A79E-F7069D552ADFQ41741654-8549BBAC-F9A8-4A19-808B-576BB5D1A5CAQ45299363-B010E602-D331-4053-8CC8-1B6E4474F6B0Q48247868-67C15D13-D938-4E7E-BD3E-8A772CA08014Q52653924-8E1730C4-A842-4570-9057-2F9D547958AEQ53060333-B4AABE2D-AB41-4E2D-B7FC-39FC364DC905Q55462096-583D4CA8-9BDF-4A7E-8388-0C561953B21AQ59714944-D0CB3879-1EDC-48AB-8258-86DEA8C79FE4Q83695394-3C728420-1ED5-4496-B1B7-310AAD62020FQ85648885-DF352F5C-44F7-48B7-B3F7-16B0E0FF58EDQ87260583-9121FC76-89E0-4D64-A6C2-514A6A9A4E39Q90618764-FEDC0BED-08E2-4658-BB06-00590BD63686Q92071850-914E3C7A-6505-40FA-8600-D4A8DDE46784Q93066031-793709D4-E68D-4E12-933F-C44EADDA0C36
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0001-9707-9357
@en
name
Benjamin H. Rotstein
@ast
Benjamin H. Rotstein
@en
Benjamin H. Rotstein
@es
Benjamin H. Rotstein
@nl
type
label
Benjamin H. Rotstein
@ast
Benjamin H. Rotstein
@en
Benjamin H. Rotstein
@es
Benjamin H. Rotstein
@nl
prefLabel
Benjamin H. Rotstein
@ast
Benjamin H. Rotstein
@en
Benjamin H. Rotstein
@es
Benjamin H. Rotstein
@nl
P108
P106
P1153
21743423200
P31
P496
0000-0001-9707-9357